LIFECORE BIOMEDICAL, INC. APIC, Share-based Payment Arrangement, Recognition and Exercise
LIFECORE BIOMEDICAL, INC. (LFCR) reported APIC, Share-based Payment Arrangement, Recognition and Exercise of $41.00 thousand for the 3-month period ending 2015-08-30, per its 10-Q filed 2015-10-01.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions · last filed 2015-10-01
- LIFECORE BIOMEDICAL, INC. apic, share-based payment arrangement, recognition and exercise for the quarter ending 2015-08-30 was $41.00K, a 1266.67% increase year-over-year.
- LIFECORE BIOMEDICAL, INC. apic, share-based payment arrangement, recognition and exercise for the quarter ending 2015-03-01 was $22.00K, a 97.54% decline year-over-year.
- LIFECORE BIOMEDICAL, INC. apic, share-based payment arrangement, recognition and exercise for the quarter ending 2014-11-30 was $97.00K, a 90.32% decline year-over-year.
- LIFECORE BIOMEDICAL, INC. apic, share-based payment arrangement, recognition and exercise for the quarter ending 2014-08-31 was $3.00K, a 98.80% decline year-over-year.
| Period end | APIC, Share-based Payment Arrangement, Recognition and Exercise 3 month | APIC, Share-based Payment Arrangement, Recognition and Exercise 6 month | APIC, Share-based Payment Arrangement, Recognition and Exercise 9 month |
|---|---|---|---|
| 2015-08-30 | $41.00K 10-Q · filed 2015-10-01 | ||
| 2015-03-01 | $22.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-02 | $119.00K derived: sum of 2 quarters · filed 2015-04-02 | $122.00K 10-Q · filed 2015-04-02 |
| 2014-11-30 | $97.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-01-09 | $100.00K 10-Q · filed 2015-01-09 | |
| 2014-08-31 | $3.00K 10-Q · filed 2014-10-08 | ||
| 2014-02-23 | $895.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-28 | $1.90M derived: sum of 2 quarters · filed 2014-03-28 | $2.15M 10-Q · filed 2014-03-28 |
| 2013-11-24 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-01-03 | $1.25M 10-Q · filed 2014-01-03 | |
| 2013-08-25 | $250.00K 10-Q · filed 2013-09-26 | ||
| 2013-02-24 | $734.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-04-04 | $1.18M derived: sum of 2 quarters · filed 2013-04-04 | $1.39M 10-Q · filed 2013-04-04 |
| 2012-11-25 | $449.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2013-01-04 | $651.00K 10-Q · filed 2013-01-04 | |
| 2012-08-26 | $202.00K 10-Q/A · filed 2013-01-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |